Ameritas Investment Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.04M Sell
55,741
-267
-0.5% -$35.2K 0.19% 86
2026
Q1
$7.81M Hold
56,008
0.24% 66
2025
Q4
$6.87M Buy
56,008
+3,266
+6% +$397K 0.21% 78
2025
Q3
$5.85M Buy
52,742
+232
+0.4% +$26.4K 0.18% 84
2025
Q2
$5.82M Sell
52,510
-132
-0.3% -$14K 0.18% 77
2025
Q1
$5.9M Buy
52,642
+848
+2% +$87.5K 0.2% 70
2024
Q4
$4.78M Buy
51,794
+1,721
+3% +$155K 0.16% 94
2024
Q3
$4.2M Buy
50,073
+822
+2% +$62.7K 0.14% 125
2024
Q2
$3.38M Sell
49,251
-367
-0.7% -$24.5K 0.12% 152
2024
Q1
$3.63M Sell
49,618
-368
-0.7% -$28.3K 0.12% 145
2023
Q4
$4.05M Buy
49,986
+1,108
+2% +$86.2K 0.15% 109
2023
Q3
$3.66M Buy
48,878
+7,012
+17% +$539K 0.15% 114
2023
Q2
$3.23M Sell
41,866
-113
-0.3% -$9.01K 0.12% 158
2023
Q1
$3.48M Hold
41,979
0.14% 136
2022
Q4
$3.49M Sell
41,979
-1,237
-3% -$98K 0.14% 132
2022
Q3
$2.67M Sell
43,216
-77
-0.2% -$4.86K 0.12% 151
2022
Q2
$2.67M Sell
43,293
-114
-0.3% -$7.06K 0.12% 161
2022
Q1
$2.58M Sell
43,407
-443
-1% -$28.3K 0.09% 232
2021
Q4
$3.18M Buy
43,850
+338
+0.8% +$23.3K 0.11% 186
2021
Q3
$3.04M Sell
43,512
-372
-0.8% -$26.1K 0.11% 176
2021
Q2
$3.02M Buy
43,884
+163
+0.4% +$10.9K 0.11% 184
2021
Q1
$2.83M Sell
43,721
-558
-1% -$36K 0.11% 189
2020
Q4
$2.58M Buy
44,279
+1,058
+2% +$63.8K 0.12% 195
2020
Q3
$2.73M Sell
43,221
-1,874
-4% -$130K 0.12% 155
2020
Q2
$3.47M Sell
45,095
-974
-2% -$74.6K 0.17% 95
2020
Q1
$3.44M Sell
46,069
-253
-0.5% -$17.5K 0.2% 76
2019
Q4
$3.01M Buy
46,322
+1,143
+3% +$74.4K 0.13% 139
2019
Q3
$2.86M Sell
45,179
-803
-2% -$52.5K 0.13% 149
2019
Q2
$3.11M Sell
45,982
-393
-0.8% -$25.9K 0.14% 127
2019
Q1
$3.02M Sell
46,375
-538
-1% -$35.8K 0.14% 127
2018
Q4
$2.93M Sell
46,913
-303
-0.6% -$21.2K 0.16% 117
2018
Q3
$3.65M Sell
47,216
-1,291
-3% -$97.5K 0.17% 106
2018
Q2
$3.44M Sell
48,507
-12,329
-20% -$871K 0.17% 105
2018
Q1
$4.58M Sell
60,836
-3,715
-6% -$295K 0.22% 63
2017
Q4
$4.59M Sell
64,551
-3,466
-5% -$263K 0.21% 78
2017
Q3
$5.65M Buy
68,017
+250
+0.4% +$19.1K 0.27% 52
2017
Q2
$4.79M Sell
67,767
-839
-1% -$55.8K 0.23% 59
2017
Q1
$4.66M Sell
68,606
-3,019
-4% -$212K 0.23% 64
2016
Q4
$5.13M Sell
71,625
-9,405
-12% -$699K 0.26% 57
2016
Q3
$6.41M Buy
81,030
+4,446
+6% +$361K 0.35% 36
2016
Q2
$6.39M Buy
76,584
+725
+1% +$64.3K 0.42% 39
2016
Q1
$6.97M Sell
75,859
-6,469
-8% -$583K 0.46% 33
2015
Q4
$8.33M Sell
82,328
-18,730
-19% -$1.95M 0.56% 21
2015
Q3
$9.92M Sell
101,058
-191
-0.2% -$21.2K 0.71% 15
2015
Q2
$11.9M Buy
101,249
+512
+0.5% +$55.9K 0.78% 15
2015
Q1
$9.88M Sell
100,737
-5,242
-5% -$532K 0.65% 18
2014
Q4
$9.99M Sell
105,979
-604
-0.6% -$62.5K 0.68% 17
2014
Q3
$11.3M Sell
106,583
-3,668
-3% -$359K 0.81% 14
2014
Q2
$9.14M Sell
110,251
-3,062
-3% -$238K 0.66% 18
2014
Q1
$8.03M Sell
113,313
-215
-0.2% -$16.9K 0.63% 19
2013
Q4
$8.53M Buy
113,528
+29,472
+35% +$2.05M 0.68% 13
2013
Q3
$5.28M Buy
84,056
+18,416
+28% +$1.1M 0.5% 32
2013
Q2
$3.37M Buy
+65,640
New +$3.42M 0.92% 13

Other funds holding GILD

Ameritas Investment Partners's GILD Position: Q2 2026 in Review

Ameritas Investment Partners reduced its Gilead Sciences (GILD) stake by 0.48% in Q2 2026, selling an estimated $35.2K and leaving 55,741 shares worth $7.04M. The position accounts for 0.19% of the portfolio, ranked #86.

Ameritas Investment Partners first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.9M in Q2 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Ameritas Investment Partners held 55,741 shares of Gilead Sciences worth $7.04M as of Q2 2026.
  • Ameritas Investment Partners sold 267 Gilead Sciences shares in Q2 2026, an estimated $35.2K.
  • Gilead Sciences made up 0.19% of Ameritas Investment Partners's portfolio in Q2 2026, its #86 holding.
  • Ameritas Investment Partners first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Ameritas Investment Partners's Gilead Sciences position peaked at $11.9M in Q2 2015.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.